about
Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction.miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression.Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cellsHistone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma.Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146aThe anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-αHBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillancePoly(I:C) exhibits an anti-cancer effect in human gastric adenocarcinoma cells which is dependent on RLRs.Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles.miR-146a negatively regulates NK cell functions via STAT1 signaling.Flow cytometric analysis of circulating follicular helper T (Tfh) and follicular regulatory T (Tfr) populations in human blood.Intracellular poly(I:C) initiated gastric adenocarcinoma cell apoptosis and subsequently ameliorated NK cell functions5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected miceProminent immune signatures of T cells are specifically associated with indolent B-cell lymphoproliferative disorders and predict prognosis
P50
Q33652113-E8FB923E-F413-4F39-A8E0-7B48CE76673CQ35157437-94C78DDB-EE78-491E-A73B-F921D4CD583EQ35203879-DFE7695B-BA4A-4507-BEA9-52B627ED77C4Q35677697-4B7A6735-39AB-4F82-8DBC-49CA57C7AB5BQ36925668-5EDBD813-FEE0-498E-8530-F6FDDB794A19Q37153828-E5D28125-FB81-4703-99CE-9339843A2BF9Q37636590-4B427425-A61B-4D6E-9370-DEEEE545AF6EQ39096689-F2A8F808-8006-4F35-AB2B-9ED90CE29C13Q40584549-5C7D337A-C650-40BA-83AC-47A591B53568Q40589864-86608541-8A18-41DC-A9CD-A4913601897DQ40748437-2C1FE251-4E3E-4819-829A-68477D20C6B7Q41360215-5D9CF415-65C0-4183-A4CB-014796DFFD65Q41863836-F5B52AC7-8DA7-48C5-92D4-66FA11391F20Q59350725-FB0C7F60-3CBC-433A-B7FE-9FF36DE95123Q93015350-A98F726F-3FFA-4F48-88E9-6D01A08BCBDA
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3093-0279
@en
name
Zhaohua Hou
@ast
Zhaohua Hou
@en
Zhaohua Hou
@es
Zhaohua Hou
@nl
type
label
Zhaohua Hou
@ast
Zhaohua Hou
@en
Zhaohua Hou
@es
Zhaohua Hou
@nl
prefLabel
Zhaohua Hou
@ast
Zhaohua Hou
@en
Zhaohua Hou
@es
Zhaohua Hou
@nl
P106
P31
P496
0000-0003-3093-0279